8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Meet Veristat in Barcelona at BIO-Europe Spring 2024, 18-20 March 2024
With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
As a flexible CRO and consultancy, we provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Don't miss this opportunity to connect with us and learn more about how Veristat is making a difference in the lives of patients with rare and ultra-rare diseases.
Where Data Becomes Direction for complex clinical programs
Veristat team member, Balma Gil, Senior Business Development Director, will be at the venue, ready to listen to your needs and share Veristat’s expertise.
You can arrange a meeting by completing the form on the right side of this page. Discover how we can assist you in progressing your upcoming clinical trial or regulatory submission towards a successful outcome or explore our wide range of capabilities.
Website: BIO EUROPE SPRING 2024
Meet with us at BIO EUROPE SPRING 2024 by filling out the form below.
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...